Expression of hepcidin mRNA is uniformly suppressed in hepatocellular carcinoma View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2008-06-09

AUTHORS

Hiroaki Kijima, Tokihiko Sawada, Naohisa Tomosugi, Keiichi Kubota

ABSTRACT

BackgroundThe present study evaluated the expression of hepcidin mRNA in hepatocellular carcinoma (HCC).MethodsSamples of cancerous and non-cancerous liver tissue were taken from 40 patients with HCC who underwent hepatectomy. Expression of hepcidin mRNA was evaluated by real-time PCR, and compared in tumors differing in their degree of differentiation, number of tumors, and vessel invasion. Correlations between hepcidin expression and the interval until HCC recurrence, and the serum concentration of hepcidin were evaluated, together with the expression of mRNAs for other iron metabolism molecules, ferroportin and transferrin receptor 2 (Trf2).ResultsHepcidin mRNA expression in non-cancerous and cancerous tissues was 1891.8 (32.3–23187.4) and 53.4 (1.9–3185.8), respectively (P < 0.0001). There were no significant differences in hepcidin expression among tumors differing in their degree of differentiation, number of tumors, or vessel invasion. There was no significant correlation between hepcidin expression and the interval until HCC recurrence. The serum concentration of hepcidin-25 was not correlated with hepcidin-mRNA expression. Finally, there were no significant differences in the expression of mRNA for ferroportin and Trf2 between cancerous and non-cancerous tissues.ConclusionExpression of hepcidin mRNA is strikingly suppressed in cancerous, but not in non-cancerous tissues, in patients with HCC, irrespective of ferroportin or Trf2 expression. Uniform suppression of hepcidin may be linked to the development of HCC. More... »

PAGES

167

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/1471-2407-8-167

DOI

http://dx.doi.org/10.1186/1471-2407-8-167

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1025796687

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/18541040


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Analysis of Variance", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antimicrobial Cationic Peptides", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Biomarkers, Tumor", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Carcinoma, Hepatocellular", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cohort Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Disease-Free Survival", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Gene Expression Regulation, Neoplastic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hepcidins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Immunohistochemistry", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Liver Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm Staging", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Probability", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prognosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "RNA, Messenger", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Reference Values", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Reverse Transcriptase Polymerase Chain Reaction", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Sensitivity and Specificity", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Statistics, Nonparametric", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Survival Analysis", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Second Department of Surgery, Dokkyo University School of Medicine, Kitakobayashi 880, Mibu, 321-0293, Shimotsuga, Tochigi, Japan", 
          "id": "http://www.grid.ac/institutes/grid.412039.d", 
          "name": [
            "Second Department of Surgery, Dokkyo University School of Medicine, Kitakobayashi 880, Mibu, 321-0293, Shimotsuga, Tochigi, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kijima", 
        "givenName": "Hiroaki", 
        "id": "sg:person.01112015611.68", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01112015611.68"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Second Department of Surgery, Dokkyo University School of Medicine, Kitakobayashi 880, Mibu, 321-0293, Shimotsuga, Tochigi, Japan", 
          "id": "http://www.grid.ac/institutes/grid.412039.d", 
          "name": [
            "Second Department of Surgery, Dokkyo University School of Medicine, Kitakobayashi 880, Mibu, 321-0293, Shimotsuga, Tochigi, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sawada", 
        "givenName": "Tokihiko", 
        "id": "sg:person.01174471365.20", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01174471365.20"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Proteomics Research Unit, Division of Advanced Medicine, Medical Research Institute, Kanazawa Medical College, Daigaku 1-1, 920-0293, Uchinada, Kanazawa, Japan", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Proteomics Research Unit, Division of Advanced Medicine, Medical Research Institute, Kanazawa Medical College, Daigaku 1-1, 920-0293, Uchinada, Kanazawa, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tomosugi", 
        "givenName": "Naohisa", 
        "id": "sg:person.01124202355.57", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01124202355.57"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Second Department of Surgery, Dokkyo University School of Medicine, Kitakobayashi 880, Mibu, 321-0293, Shimotsuga, Tochigi, Japan", 
          "id": "http://www.grid.ac/institutes/grid.412039.d", 
          "name": [
            "Second Department of Surgery, Dokkyo University School of Medicine, Kitakobayashi 880, Mibu, 321-0293, Shimotsuga, Tochigi, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kubota", 
        "givenName": "Keiichi", 
        "id": "sg:person.01242604565.31", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01242604565.31"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/sj.onc.1209547", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035861624", 
          "https://doi.org/10.1038/sj.onc.1209547"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/ncpgasthep0019", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007438974", 
          "https://doi.org/10.1038/ncpgasthep0019"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1111/j.1572-0241.2004.04049.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014368211", 
          "https://doi.org/10.1111/j.1572-0241.2004.04049.x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/351453a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052393971", 
          "https://doi.org/10.1038/351453a0"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2008-06-09", 
    "datePublishedReg": "2008-06-09", 
    "description": "BackgroundThe present study evaluated the expression of hepcidin mRNA in hepatocellular carcinoma (HCC).MethodsSamples of cancerous and non-cancerous liver tissue were taken from 40 patients with HCC who underwent hepatectomy. Expression of hepcidin mRNA was evaluated by real-time PCR, and compared in tumors differing in their degree of differentiation, number of tumors, and vessel invasion. Correlations between hepcidin expression and the interval until HCC recurrence, and the serum concentration of hepcidin were evaluated, together with the expression of mRNAs for other iron metabolism molecules, ferroportin and transferrin receptor 2 (Trf2).ResultsHepcidin mRNA expression in non-cancerous and cancerous tissues was 1891.8 (32.3\u201323187.4) and 53.4 (1.9\u20133185.8), respectively (P < 0.0001). There were no significant differences in hepcidin expression among tumors differing in their degree of differentiation, number of tumors, or vessel invasion. There was no significant correlation between hepcidin expression and the interval until HCC recurrence. The serum concentration of hepcidin-25 was not correlated with hepcidin-mRNA expression. Finally, there were no significant differences in the expression of mRNA for ferroportin and Trf2 between cancerous and non-cancerous tissues.ConclusionExpression of hepcidin mRNA is strikingly suppressed in cancerous, but not in non-cancerous tissues, in patients with HCC, irrespective of ferroportin or Trf2 expression. Uniform suppression of hepcidin may be linked to the development of HCC.", 
    "genre": "article", 
    "id": "sg:pub.10.1186/1471-2407-8-167", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1024632", 
        "issn": [
          "1471-2407"
        ], 
        "name": "BMC Cancer", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "8"
      }
    ], 
    "keywords": [
      "number of tumors", 
      "hepatocellular carcinoma", 
      "hepcidin mRNA", 
      "non-cancerous tissues", 
      "expression of mRNA", 
      "hepcidin expression", 
      "HCC recurrence", 
      "vessel invasion", 
      "serum concentrations", 
      "degree of differentiation", 
      "development of HCC", 
      "hepcidin mRNA expression", 
      "significant differences", 
      "non-cancerous liver tissues", 
      "BackgroundThe present study", 
      "transferrin receptor 2", 
      "real-time PCR", 
      "receptor 2", 
      "hepcidin-25", 
      "liver tissue", 
      "mRNA expression", 
      "tumors", 
      "uniform suppression", 
      "ferroportin", 
      "carcinoma", 
      "patients", 
      "recurrence", 
      "significant correlation", 
      "TRF2 expression", 
      "metabolism molecules", 
      "cancerous tissues", 
      "hepcidin", 
      "tissue", 
      "present study", 
      "mRNA", 
      "expression", 
      "invasion", 
      "hepatectomy", 
      "differentiation", 
      "interval", 
      "ConclusionExpression", 
      "differences", 
      "PCR", 
      "correlation", 
      "MethodsSamples", 
      "concentration", 
      "suppression", 
      "study", 
      "number", 
      "degree", 
      "development", 
      "TRF2", 
      "molecules"
    ], 
    "name": "Expression of hepcidin mRNA is uniformly suppressed in hepatocellular carcinoma", 
    "pagination": "167", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1025796687"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/1471-2407-8-167"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "18541040"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/1471-2407-8-167", 
      "https://app.dimensions.ai/details/publication/pub.1025796687"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-12-01T06:26", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/article/article_455.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1186/1471-2407-8-167"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/1471-2407-8-167'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/1471-2407-8-167'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/1471-2407-8-167'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/1471-2407-8-167'


 

This table displays all metadata directly associated to this object as RDF triples.

249 TRIPLES      21 PREDICATES      106 URIs      94 LITERALS      31 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/1471-2407-8-167 schema:about N089a4ebd7d294a5e82b82a74954666ae
2 N0f7161ec178e46f2af1e6e30514da8af
3 N2123a49c97df4c52934afb14a94806d1
4 N2f9dd2fc5ea441f48bee9bf07d59be22
5 N334a07ac0ec14072b21896cd1831948f
6 N4128bf402eb3402698d720326e3d787d
7 N4513312e8ff443ea8f70c28fc0fdff9e
8 N47ecf081874c49b6854a6ecc7dc484e0
9 N4f7222e18f11426aa4e7ef7a1c3ad023
10 N5c1717cfb84f49acb52d4c9dcd70a27f
11 N5d5a3bbbf3d0402498b7f7d817075dbe
12 N716e24a62cb24eae8c7a5fb55c7fb63d
13 N752d34de24fe45fd943b721bd5bc0e9d
14 N851bd9cbfd544685be00ab2d4c860420
15 N8b2f33e75d0e463baf2d71bbe65544ef
16 N9126c63fb6ff4ab190a25b0ec8cd640f
17 N95fcaa6b66144e19a73e3ff98780cc3c
18 N980130fcb4c54fc1b053569cc6d6b2b3
19 Nafe7946483214304a72289a78661095c
20 Nd82c4fa243944c739049944422d9042b
21 Ne3b06835741a49e18ba4f04fc3076e71
22 Ne719f5b29c274132907c52764b6ea70d
23 Nec25a28f812c4141b15c881ddf37773b
24 Nf43875c05b5246fd84d7252757b09f14
25 anzsrc-for:11
26 anzsrc-for:1112
27 schema:author Nd44436a185ce4185adcdd73a6d42ea80
28 schema:citation sg:pub.10.1038/351453a0
29 sg:pub.10.1038/ncpgasthep0019
30 sg:pub.10.1038/sj.onc.1209547
31 sg:pub.10.1111/j.1572-0241.2004.04049.x
32 schema:datePublished 2008-06-09
33 schema:datePublishedReg 2008-06-09
34 schema:description BackgroundThe present study evaluated the expression of hepcidin mRNA in hepatocellular carcinoma (HCC).MethodsSamples of cancerous and non-cancerous liver tissue were taken from 40 patients with HCC who underwent hepatectomy. Expression of hepcidin mRNA was evaluated by real-time PCR, and compared in tumors differing in their degree of differentiation, number of tumors, and vessel invasion. Correlations between hepcidin expression and the interval until HCC recurrence, and the serum concentration of hepcidin were evaluated, together with the expression of mRNAs for other iron metabolism molecules, ferroportin and transferrin receptor 2 (Trf2).ResultsHepcidin mRNA expression in non-cancerous and cancerous tissues was 1891.8 (32.3–23187.4) and 53.4 (1.9–3185.8), respectively (P < 0.0001). There were no significant differences in hepcidin expression among tumors differing in their degree of differentiation, number of tumors, or vessel invasion. There was no significant correlation between hepcidin expression and the interval until HCC recurrence. The serum concentration of hepcidin-25 was not correlated with hepcidin-mRNA expression. Finally, there were no significant differences in the expression of mRNA for ferroportin and Trf2 between cancerous and non-cancerous tissues.ConclusionExpression of hepcidin mRNA is strikingly suppressed in cancerous, but not in non-cancerous tissues, in patients with HCC, irrespective of ferroportin or Trf2 expression. Uniform suppression of hepcidin may be linked to the development of HCC.
35 schema:genre article
36 schema:isAccessibleForFree true
37 schema:isPartOf N33e956b6988c4acb8d907cd05429a7bf
38 Nae9420cc88ef41619bd0b4778298e543
39 sg:journal.1024632
40 schema:keywords BackgroundThe present study
41 ConclusionExpression
42 HCC recurrence
43 MethodsSamples
44 PCR
45 TRF2
46 TRF2 expression
47 cancerous tissues
48 carcinoma
49 concentration
50 correlation
51 degree
52 degree of differentiation
53 development
54 development of HCC
55 differences
56 differentiation
57 expression
58 expression of mRNA
59 ferroportin
60 hepatectomy
61 hepatocellular carcinoma
62 hepcidin
63 hepcidin expression
64 hepcidin mRNA
65 hepcidin mRNA expression
66 hepcidin-25
67 interval
68 invasion
69 liver tissue
70 mRNA
71 mRNA expression
72 metabolism molecules
73 molecules
74 non-cancerous liver tissues
75 non-cancerous tissues
76 number
77 number of tumors
78 patients
79 present study
80 real-time PCR
81 receptor 2
82 recurrence
83 serum concentrations
84 significant correlation
85 significant differences
86 study
87 suppression
88 tissue
89 transferrin receptor 2
90 tumors
91 uniform suppression
92 vessel invasion
93 schema:name Expression of hepcidin mRNA is uniformly suppressed in hepatocellular carcinoma
94 schema:pagination 167
95 schema:productId N077cd80540784d23ac39d8e1bc5365d3
96 N36ab2fdb81464e6db084cbf9625baaa9
97 Nebf05a25a16d42be933e06516a581be0
98 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025796687
99 https://doi.org/10.1186/1471-2407-8-167
100 schema:sdDatePublished 2022-12-01T06:26
101 schema:sdLicense https://scigraph.springernature.com/explorer/license/
102 schema:sdPublisher Na5ba3c373cd1474e8da192124f9e446f
103 schema:url https://doi.org/10.1186/1471-2407-8-167
104 sgo:license sg:explorer/license/
105 sgo:sdDataset articles
106 rdf:type schema:ScholarlyArticle
107 N077cd80540784d23ac39d8e1bc5365d3 schema:name pubmed_id
108 schema:value 18541040
109 rdf:type schema:PropertyValue
110 N089a4ebd7d294a5e82b82a74954666ae schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
111 schema:name Liver Neoplasms
112 rdf:type schema:DefinedTerm
113 N0f7161ec178e46f2af1e6e30514da8af schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
114 schema:name Hepcidins
115 rdf:type schema:DefinedTerm
116 N180767820ef14d7f9c6841a130f45893 rdf:first sg:person.01242604565.31
117 rdf:rest rdf:nil
118 N2123a49c97df4c52934afb14a94806d1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
119 schema:name Statistics, Nonparametric
120 rdf:type schema:DefinedTerm
121 N2f9dd2fc5ea441f48bee9bf07d59be22 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
122 schema:name Aged
123 rdf:type schema:DefinedTerm
124 N334a07ac0ec14072b21896cd1831948f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Carcinoma, Hepatocellular
126 rdf:type schema:DefinedTerm
127 N33e956b6988c4acb8d907cd05429a7bf schema:issueNumber 1
128 rdf:type schema:PublicationIssue
129 N36ab2fdb81464e6db084cbf9625baaa9 schema:name doi
130 schema:value 10.1186/1471-2407-8-167
131 rdf:type schema:PropertyValue
132 N4128bf402eb3402698d720326e3d787d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
133 schema:name Immunohistochemistry
134 rdf:type schema:DefinedTerm
135 N4513312e8ff443ea8f70c28fc0fdff9e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
136 schema:name Male
137 rdf:type schema:DefinedTerm
138 N47ecf081874c49b6854a6ecc7dc484e0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
139 schema:name Disease-Free Survival
140 rdf:type schema:DefinedTerm
141 N4f7222e18f11426aa4e7ef7a1c3ad023 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
142 schema:name Reverse Transcriptase Polymerase Chain Reaction
143 rdf:type schema:DefinedTerm
144 N5c1717cfb84f49acb52d4c9dcd70a27f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
145 schema:name Antimicrobial Cationic Peptides
146 rdf:type schema:DefinedTerm
147 N5d5a3bbbf3d0402498b7f7d817075dbe schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name Reference Values
149 rdf:type schema:DefinedTerm
150 N716e24a62cb24eae8c7a5fb55c7fb63d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
151 schema:name Sensitivity and Specificity
152 rdf:type schema:DefinedTerm
153 N752d34de24fe45fd943b721bd5bc0e9d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
154 schema:name Middle Aged
155 rdf:type schema:DefinedTerm
156 N851bd9cbfd544685be00ab2d4c860420 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
157 schema:name Prognosis
158 rdf:type schema:DefinedTerm
159 N8b2f33e75d0e463baf2d71bbe65544ef schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
160 schema:name Probability
161 rdf:type schema:DefinedTerm
162 N9126c63fb6ff4ab190a25b0ec8cd640f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
163 schema:name Biomarkers, Tumor
164 rdf:type schema:DefinedTerm
165 N95fcaa6b66144e19a73e3ff98780cc3c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
166 schema:name Cohort Studies
167 rdf:type schema:DefinedTerm
168 N980130fcb4c54fc1b053569cc6d6b2b3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
169 schema:name Neoplasm Staging
170 rdf:type schema:DefinedTerm
171 Na5ba3c373cd1474e8da192124f9e446f schema:name Springer Nature - SN SciGraph project
172 rdf:type schema:Organization
173 Nae9420cc88ef41619bd0b4778298e543 schema:volumeNumber 8
174 rdf:type schema:PublicationVolume
175 Nafe7946483214304a72289a78661095c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
176 schema:name Analysis of Variance
177 rdf:type schema:DefinedTerm
178 Nb7f54ae723744a04ac5b25ce13eaf3ae rdf:first sg:person.01124202355.57
179 rdf:rest N180767820ef14d7f9c6841a130f45893
180 Nd44436a185ce4185adcdd73a6d42ea80 rdf:first sg:person.01112015611.68
181 rdf:rest Nd536da3e827749be8b3dae47ac70ef09
182 Nd536da3e827749be8b3dae47ac70ef09 rdf:first sg:person.01174471365.20
183 rdf:rest Nb7f54ae723744a04ac5b25ce13eaf3ae
184 Nd82c4fa243944c739049944422d9042b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
185 schema:name Survival Analysis
186 rdf:type schema:DefinedTerm
187 Ne3b06835741a49e18ba4f04fc3076e71 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
188 schema:name RNA, Messenger
189 rdf:type schema:DefinedTerm
190 Ne719f5b29c274132907c52764b6ea70d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
191 schema:name Female
192 rdf:type schema:DefinedTerm
193 Nebf05a25a16d42be933e06516a581be0 schema:name dimensions_id
194 schema:value pub.1025796687
195 rdf:type schema:PropertyValue
196 Nec25a28f812c4141b15c881ddf37773b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
197 schema:name Humans
198 rdf:type schema:DefinedTerm
199 Nf43875c05b5246fd84d7252757b09f14 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
200 schema:name Gene Expression Regulation, Neoplastic
201 rdf:type schema:DefinedTerm
202 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
203 schema:name Medical and Health Sciences
204 rdf:type schema:DefinedTerm
205 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
206 schema:name Oncology and Carcinogenesis
207 rdf:type schema:DefinedTerm
208 sg:journal.1024632 schema:issn 1471-2407
209 schema:name BMC Cancer
210 schema:publisher Springer Nature
211 rdf:type schema:Periodical
212 sg:person.01112015611.68 schema:affiliation grid-institutes:grid.412039.d
213 schema:familyName Kijima
214 schema:givenName Hiroaki
215 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01112015611.68
216 rdf:type schema:Person
217 sg:person.01124202355.57 schema:affiliation grid-institutes:None
218 schema:familyName Tomosugi
219 schema:givenName Naohisa
220 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01124202355.57
221 rdf:type schema:Person
222 sg:person.01174471365.20 schema:affiliation grid-institutes:grid.412039.d
223 schema:familyName Sawada
224 schema:givenName Tokihiko
225 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01174471365.20
226 rdf:type schema:Person
227 sg:person.01242604565.31 schema:affiliation grid-institutes:grid.412039.d
228 schema:familyName Kubota
229 schema:givenName Keiichi
230 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01242604565.31
231 rdf:type schema:Person
232 sg:pub.10.1038/351453a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052393971
233 https://doi.org/10.1038/351453a0
234 rdf:type schema:CreativeWork
235 sg:pub.10.1038/ncpgasthep0019 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007438974
236 https://doi.org/10.1038/ncpgasthep0019
237 rdf:type schema:CreativeWork
238 sg:pub.10.1038/sj.onc.1209547 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035861624
239 https://doi.org/10.1038/sj.onc.1209547
240 rdf:type schema:CreativeWork
241 sg:pub.10.1111/j.1572-0241.2004.04049.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1014368211
242 https://doi.org/10.1111/j.1572-0241.2004.04049.x
243 rdf:type schema:CreativeWork
244 grid-institutes:None schema:alternateName Proteomics Research Unit, Division of Advanced Medicine, Medical Research Institute, Kanazawa Medical College, Daigaku 1-1, 920-0293, Uchinada, Kanazawa, Japan
245 schema:name Proteomics Research Unit, Division of Advanced Medicine, Medical Research Institute, Kanazawa Medical College, Daigaku 1-1, 920-0293, Uchinada, Kanazawa, Japan
246 rdf:type schema:Organization
247 grid-institutes:grid.412039.d schema:alternateName Second Department of Surgery, Dokkyo University School of Medicine, Kitakobayashi 880, Mibu, 321-0293, Shimotsuga, Tochigi, Japan
248 schema:name Second Department of Surgery, Dokkyo University School of Medicine, Kitakobayashi 880, Mibu, 321-0293, Shimotsuga, Tochigi, Japan
249 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...